“COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER” (2017) Voprosy onkologii, 63(1), pp. 38–51. doi:10.37469/0507-3758-2017-63-1-38-51.